These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. Masi G; Cosenza A; Millepiedi S; Muratori F; Pari C; Salvadori F CNS Drugs; 2009; 23(6):511-21. PubMed ID: 19480469 [TBL] [Abstract][Full Text] [Related]
26. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study. Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215 [TBL] [Abstract][Full Text] [Related]
27. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy. Shukla G; Gupta A; Agarwal P; Poornima S Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024 [TBL] [Abstract][Full Text] [Related]
28. Carbamazepine for Irritability and Aggression after Traumatic Brain Injury: A Randomized, Placebo-Controlled Study. Hammond FM; Zafonte RD; Tang Q; Jang JH J Neurotrauma; 2021 Aug; 38(16):2238-2246. PubMed ID: 33563104 [TBL] [Abstract][Full Text] [Related]
29. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. Stigler KA; Diener JT; Kohn AE; Li L; Erickson CA; Posey DJ; McDougle CJ J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):265-74. PubMed ID: 19519261 [TBL] [Abstract][Full Text] [Related]
30. Oxcarbazepine for neuropathic pain. Zhou M; Chen N; He L; Yang M; Zhu C; Wu F Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767 [TBL] [Abstract][Full Text] [Related]
32. Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. Buitelaar JK; van der Gaag RJ; van der Hoeven J J Clin Psychiatry; 1998 Feb; 59(2):56-9. PubMed ID: 9501886 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of carbamazepine for benzodiazepine-resistant impulsive aggression in a patient with frontal infarctions. Nagata T; Harada D; Aoki K; Kada H; Miyata H; Kasahara H; Nakayama K Psychiatry Clin Neurosci; 2007 Dec; 61(6):695-7. PubMed ID: 18081636 [TBL] [Abstract][Full Text] [Related]
35. A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder. Wink LK; Adams R; Horn PS; Tessier CR; Bantel AP; Hong M; Shaffer RC; Pedapati EV; Erickson CA J Autism Dev Disord; 2018 Sep; 48(9):3051-3060. PubMed ID: 29644582 [TBL] [Abstract][Full Text] [Related]
36. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. Sommer OH; Aga O; Cvancarova M; Olsen IC; Selbaek G; Engedal K Dement Geriatr Cogn Disord; 2009; 27(2):155-63. PubMed ID: 19182483 [TBL] [Abstract][Full Text] [Related]
37. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial. Levine SZ; Kodesh A; Goldberg Y; Reichenberg A; Furukawa TA; Kolevzon A; Leucht S Eur Psychiatry; 2016 Feb; 32():16-20. PubMed ID: 26802979 [TBL] [Abstract][Full Text] [Related]
38. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343 [TBL] [Abstract][Full Text] [Related]
39. Psychopharmacologic management of serious behavioral disturbance in ASD. Stigler KA Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):73-82. PubMed ID: 24231168 [TBL] [Abstract][Full Text] [Related]
40. Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder. Malek-Ahmadi P; Hanretta AT Ann Pharmacother; 2004 Nov; 38(11):1852-4. PubMed ID: 15479776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]